Generex Biotechnology Corp. (GNBT) Develops Chewing Gum Product for Type 2 Diabetes Treatment
Generex Biotechnology Corp. (Nasdaq: GNBT) is a leader in drug delivery for metabolic diseases through the inner lining of the…
Generex Biotechnology Corp. (Nasdaq: GNBT) is a leader in drug delivery for metabolic diseases through the inner lining of the…
Analyzing test data is a prudent first step before committing to any unknown risk/reward scenario. This is the primary tenant…
MoneyShow.com, the premier source for stock market and financial market information and worldwide investor seminars, began its 4-day Las Vegas…
Hybrid Technologies announced today that it is nearing the debut of its platform of financing options which will be offered…
Did you know that QualityStocks.net currently sifts through hundreds of investment newsletters on a daily basis to produce “The QualityStocks…
A few years ago, as a wedding gift of sorts, one of our writer’s friends was presented with stock in…
Finding the right lease is the name of the game in technology oil recovery. There is plenty of oil left…
You can't blame Spire Corp. for basking in the sunshine of success when it comes to their business. As a…
In this information age, Learning Tree International (LTRE) knows the importance of specialized training for business professionals. Their focus is…
On May 8, USA Today devoted a full page to information on Hybrid Technologies, Inc., including details on the promising…